Food & Drug Administration | eHealth News | Page 60

The U.S. Food and Drug Administration has approved Cosentyx (secukinumab) to treat adults with moderate-to-severe plaque psoriasis.

FDA Approves New Drug to Treat Plaque Psoriasis

HealthDay.com - Jan 21, 2015

Cosentyx hinders protein that spurs skin inflammation

A new electrical stimulation device designed to control obesity by targeting the nerve pathways between the brain and stomach that regulate hunger and fullness has been approved by the U.S. Food and Drug Administration.

FDA: Stimulation Device Approved to Treat Obesity

HealthDay.com - Jan 14, 2015

Targets vagus nerve which regulates hunger

1...58 5960Page 60 of 60

Archives